Hydrogel composition

US2017145203A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2017145203-A1
Application numberUS-201615381578-A
CountryUS
Kind codeA1
Filing dateDec 16, 2016
Priority dateOct 28, 2004
Publication dateMay 25, 2017
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

An electrochemical sensor system comprises an electrochemical sensor and a hydrogel composition. The electrochemical sensor has at least a counter electrode and a working electrode. The hydrogel composition contacts the working electrode. The hydrogel composition comprises a first monomer, a second monomer, a cross-linking agent, and a solvent. The first monomer has hydrophilic characteristics. The second monomer has hydrophobic characteristics. The ratio of the first monomer to the second monomer is from about 0.1:99.9 to about 99.9:0.1.

First claim

Opening claim text (preview).

1 - 71 . (canceled) 72 . A method of determining an analyte concentration, the method comprising the acts of: placing a hydrogel composition on skin, the hydrogel composition comprising a first monomer, a second monomer, a cross-linking agent, and a solvent, the first monomer being selected from Formula I, wherein Formula I is wherein the combination of R and R1 is selected from 1 carbon to 5 carbon atoms such that a 3-7 member heterocyclic moiety is formed; the second monomer being selected from the group consisting of Formula II and Formula III, wherein Formula II is wherein R3 and R4 are independently selected from H, CH 3 , (C 3 -C 18 )alkyl, wherein the alkyl is optionally substituted with one or more substituents selected from halos, haloalkyls, cycloalkyls, nitros, cyanos, 4-8 member heterocyclic moieties, wherein the heterocyclic moieties are optionally substituted with one or more alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos; (C 3 -C 7 )cycloalkyl, wherein the cycloalkyl is optionally substituted with one or more substituents selected from alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos; and aromatic moieties, wherein the aromatic moieties are optionally substituted with one or more substituents selected from alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos, with the proviso that when R3 is H or CH 3 , then R4 is (C 3 -C 18 )alkyl, (C 3 -C 7 )cycloalkyl or an aromatic moiety, wherein the alkyl, cycloalkyl or aromatic moiety is optionally substituted with one or more substituents, with the proviso that when R4 is H or CH 3 , then R3 is (C 3 -C 18 )alkyl, (C 3 -C 7 )cycloalkyl or an aromatic moiety, wherein the alkyl, cycloalkyl or aromatic moiety is optionally substituted with one or more substituents; and wherein Formula III is wherein R5 is selected from (C 3 -C 18 )alkyl, wherein the alkyl is optionally substituted with one or more substituents selected from halos, haloalkyls, cycloalkyls, nitros, cyanos, 4-8 member heterocyclic moieties, wherein the heterocyclic moieties are optionally substituted with one or more alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos; (C 3 -C 7 )cycloalkyl, wherein the cycloalkyl is optionally substituted with one or more substituents selected from alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos; and aromatic moieties, wherein the aromatic moieties are optionally substituted with one or more substituents selected from alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos, wherein the ratio of the first monomer to the second monomer is from about 20:80 to about 80:20; providing a sensor, the hydrogel composition located generally between and coupling the skin and the sensor; and sampling of the interstitial fluid to determine the analyte concentration using the sensor. 73 . The method of claim 72 , wherein the analyte is glucose. 74 . The method of claim 72 , wherein the sensor is an electrochemical sensor. 75 . The method of claim 72 , wherein the ratio of the first monomer to the second monomer is from about 40:60 to about 60:40. 76 . The method of claim 72 , wherein the second monomer is selected from Formula II. 77 . The method of claim 72 , wherein the second monomer is selected from Formula III. 78 . The method of claim 72 , wherein the first monomer is N-vinyl acetamide, N-vinyl propionamide, N-vinyl pyrrolidone or N-vinyl caprolactam, the second monomer being selected from Formula II with R3 or R4 being a (C 3 -C 18 )alkyl that is optionally substituted. 79 . The method of claim 72 , wherein the first monomer is N-vinyl acetamide, N-vinyl propionamide, N-vinyl pyrrolidone or N-vinyl caprolactam, the second monomer being selected from Formula II with R3 or R4 being a (C 3 -C 7 )cycloalkyl that is optionally substituted. 80 . The method of claim 72 , wherein the first monomer is N-vinyl acetamide, N-vinyl propionamide, N-vinyl pyrrolidone or N-vinyl caprolactam, the second monomer being selected from Formula II with R3 or R4 being an aromatic moiety that is optionally substituted. 81 . The method of claim 72 , wherein the first monomer is N-vinyl pyrrolidone or N-vinyl caprolactam, the second monomer being selected from Formula III with R5 being a (C 3 -C 18 )alkyl that is optionally substituted. 82 . The method of claim 72 , wherein the first monomer is N-vinyl pyrrolidone or N-vinyl caprolactam, the second monomer being selected from Formula III with R5 being a (C 3 -C 7 )cycloalkyl that is optionally substituted. 83 . The method of claim 72 , wherein the first monomer is N-vinyl pyrrolidone or N-vinyl caprolactam, the second monomer being selected from Formula III with R5 being an aromatic moiety that is optionally substituted. 84 . A method of determining an analyte concentration, the method comprising the acts of: placing a hydrogel composition on skin, the hydrogel composition contacting the working electrode, the hydrogel composition comprising a first monomer, a second monomer, a cross-linking agent, and a solvent, the first monomer being selected from Formula I wherein the combination of R and R1 is selected from 1 carbon to 5 carbon atoms such that a 3-7 member heterocyclic moiety is formed; the second monomer being selected from Formula IV, wherein Formula IV is wherein R2 is selected from (C 1 -C 18 )alkyl, wherein the alkyl is optionally substituted with one or more substituents selected from halos, haloalkyls, cycloalkyls, nitros, cyanos, 4-8 member heterocyclic moieties, wherein the heterocyclic moieties are optionally substituted with one or more alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos; (C 3 -C 7 )cycloalkyl, wherein the cycloalkyl is optionally substituted with one or more substituents selected from alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos; and aromatic moieties, wherein the aromatic moieties are optionally substituted with one or more substituents selected from alkyls, halos, haloalkyls, cycloalkyls, nitros, and cyanos, wherein the ratio of the first monomer to the second monomer is from about 20:80 to about 80:20; providing a sensor, the hydrogel composition located generally between and coupling the skin and the sensor; and sampling of the interstitial fluid to determine the analyte concentration using the sensor. 85 . The method of claim 84 , wherein the ratio of the first monomer to the second monomer is from about 40:60 to about 60:40. 86 . A method of determining an analyte concentration, the method comprising the acts of: placing a hydrogel composition on skin, the hydrogel composition comprising a first monomer, a second monomer, a cross-linking agent, and a solvent, the first monomer being selected from the group consisting of N-vinyl pyrrolidone, hydroxy alkyl methacrylates, acrylamide, and N,N di-alkyl acrylamides, the second monomer being selected from the group consisting of alkyl (meth)acrylates, N-vinyl acylamide, vinyl esters, and vinyl ethers, and wherein the ratio of the first monomer to the second monomer is fro

Assignees

Inventors

Classifications

  • Glucose · CPC title

  • using enzyme electrodes, e.g. with immobilised oxidase · CPC title

  • measuring a particular property of an electrolyte · CPC title

  • Homopolymers or copolymers of amides or imides · CPC title

  • Wristwatch-type devices · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2017145203A1 cover?
An electrochemical sensor system comprises an electrochemical sensor and a hydrogel composition. The electrochemical sensor has at least a counter electrode and a working electrode. The hydrogel composition contacts the working electrode. The hydrogel composition comprises a first monomer, a second monomer, a cross-linking agent, and a solvent. The first monomer has hydrophilic characteristics.…
Who is the assignee on this patent?
Ascensia Diabetes Care Holdings Ag
What technology area does this patent fall under?
Primary CPC classification C08L33/26. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu May 25 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).